ID

28330

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product (Liver)

Keywords

  1. 10/11/17 10/11/17 -
  2. 10/16/17 10/16/17 -
  3. 10/16/17 10/16/17 -
  4. 10/23/17 10/23/17 -
  5. 1/4/18 1/4/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

January 4, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Investigational product (Liver) GSK study Chronic Coronary Heart Disease NCT00799903

Investigational product (Liver) GSK study Chronic Coronary Heart Disease NCT00799903

If the liver event occurred during treatment period record start and stop date of investigational product for that treatment period.
Description

If the liver event occurred during treatment period record start and stop date of investigational product for that treatment period.

1. Start Date Investigational Product [-99]
Description

Start Date Investigational Product treatment period

Data type

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
1. Start Date Investigational Product not applicable [-98]
Description

Start Date Investigational Product treatment period not applicable

Data type

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
2. End Date Investigational Product [-99]
Description

End Date Investigational Product treatment period

Data type

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C2361259
2. End Date Investigational Product not applicable [-98]
Description

End Date Investigational Product treatment period not applicable

Data type

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C2361259
UMLS CUI [1,3]
C1272460
If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.
Description

If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.

3. Start Date Investigational Product [-99]
Description

Start Date Investigational Product

Data type

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
3. Start Date Investigational Product not applicable [-98]
Description

Start Date Investigational Product not applicable

Data type

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
4. End Date Investigational Product [-99]
Description

End Date Investigational Product

Data type

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C2361259
4. End Date Investigational Product not applicable [-98]
Description

End Date Investigational Product not applicable

Data type

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C2361259
UMLS CUI [1,3]
C1272460

Similar models

Investigational product (Liver) GSK study Chronic Coronary Heart Disease NCT00799903

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
If the liver event occurred during treatment period record start and stop date of investigational product for that treatment period.
Start Date Investigational Product treatment period
Item
1. Start Date Investigational Product [-99]
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date Investigational Product treatment period not applicable
Item
1. Start Date Investigational Product not applicable [-98]
boolean
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
End Date Investigational Product treatment period
Item
2. End Date Investigational Product [-99]
date
C0304229 (UMLS CUI [1,1])
C2361259 (UMLS CUI [1,2])
End Date Investigational Product treatment period not applicable
Item
2. End Date Investigational Product not applicable [-98]
boolean
C0304229 (UMLS CUI [1,1])
C2361259 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
Item Group
If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.
Start Date Investigational Product
Item
3. Start Date Investigational Product [-99]
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date Investigational Product not applicable
Item
3. Start Date Investigational Product not applicable [-98]
boolean
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
End Date Investigational Product
Item
4. End Date Investigational Product [-99]
date
C0304229 (UMLS CUI [1,1])
C2361259 (UMLS CUI [1,2])
End Date Investigational Product not applicable
Item
4. End Date Investigational Product not applicable [-98]
boolean
C0304229 (UMLS CUI [1,1])
C2361259 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial